(Q39141333)

English

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.

scientific article published on 10 June 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Edson Mendes de Oliveira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Felipe Augusto Dörr

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Melissa Cavalheiro Tourino

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Luziane Potrich Bellé

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Franciele Hinterholz Knebel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Renata Chaves Albuquerque

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sabrina Sayori Okada

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Silene Migliorini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Irene Silva Soares

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ana Campa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

10 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Cell Biochemistry & Function

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

361-364

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754498%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Immune suppression in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Rational design of indoleamine 2,3-dioxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Expression and purification of recombinant human indoleamine 2, 3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Natural innate and adaptive immunity to cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Cancer: Why tumours eat tryptophan

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Predicting new molecular targets for known drugs

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

1 reference

https://api.crossref.org/works/10.1002%2FCBF.2980

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39141333&oldid=1450969502"